Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $14.1050 (-6.15%) ($13.9000 - $14.1050) on Mon. Mar. 14, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.59% (three month average) | RSI | 49 | Latest Price | $14.1050(-6.15%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.3% a day on average for past five trading days. | Weekly Trend | EDIT declines -1.4% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(69%) IWO(63%) IBUY(62%) IWC(62%) IWM(60%) | Factors Impacting EDIT price | EDIT will decline at least -2.295% in a week (0% probabilities). VIXM(-31%) UUP(-16%) VXX(-11%) TBT(-11%) EDOC(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.295% (StdDev 4.59%) | Hourly BBV | -1.7 () | Intraday Trend | 0% | | | |
|
Resistance Level | $16.02 | 5 Day Moving Average | $15.59(-9.53%) | 10 Day Moving Average | $16.08(-12.28%) | 20 Day Moving Average | $16.02(-11.95%) | To recent high | -53.4% | To recent low | 0% | Market Cap | $876m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |